Endoscopic Transsphenoidal Surgery of Microprolactinomas: A Reappraisal of Cure Rate Based on Radiological Criteria

Abstract Background Current standard treatment of microprolactinomas is dopamine agonist therapy. As this drug treatment is lifelong in up to 80% of cases, many patients consult pituitary surgeons regarding a surgical alternative. Objective To identify prognostic criteria for surgical remission, we...

Full description

Saved in:

Bibliographic Details
Published in:	Neurosurgery Vol. 85; no. 4; pp. 508 - 515
Main Authors:	Micko, Alexander, Vila, Greisa, Höftberger, Romana, Knosp, Engelbert, Wolfsberger, Stefan
Format:	Journal Article
Language:	English
Published:	United States Oxford University Press 01.10.2019 Copyright by the Congress of Neurological Surgeons Wolters Kluwer Health, Inc
Subjects:	Adult Aged Agonists Cabergoline Cohort Studies Endoscopy Female Humans Logistic Models Magnetic Resonance Imaging - methods Male Middle Aged Neuroendoscopy - methods Neurosurgery Pituitary gland Pituitary Neoplasms - diagnostic imaging Pituitary Neoplasms - pathology Pituitary Neoplasms - surgery Prognosis Prolactin Prolactinoma - diagnostic imaging Prolactinoma - pathology Prolactinoma - surgery Surgeons Surgery Treatment Outcome Tumors Young Adult Austria Endoscopic surgery Medial cavernous sinus wall Microprolactinoma Dopamin agonist treatment
ISSN:	0148-396X, 1524-4040, 1524-4040
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!